Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Amyloidopathy, Cholinopathy, Dopamine Responsiveness and Freezing of Gait in PD

Authors not listed

VA Office of Research and Development · 2016

Abstract

Early stage Parkinson disease (PD) is characterized by a 'honeymoon' phase in terms of responsiveness of motor symptoms, including gait, to dopaminergic pharmacotherapy. Advancing PD is associated with disabling axial motor complications, such as freezing of gait (FoG), with decreased or even refractory dopamine responsiveness in over 50% of patients. The management of dopamine resistant gait problems represents the most important unmet need in PD. This study will related detailed motor testing to brain PET imaging to see if certain molecules (or lack thereof) involved with neurologic transmission in the brain are involved with FoG.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-14 MST

Cite this

APA
Anonymous. (2016). Amyloidopathy, Cholinopathy, Dopamine Responsiveness and Freezing of Gait in PD. <em>VA Office of Research and Development</em>. https://clinicaltrials.gov/study/NCT03647137
Vancouver
Anonymous. Amyloidopathy, Cholinopathy, Dopamine Responsiveness and Freezing of Gait in PD. VA Office of Research and Development. 2016.
BibTeX
@misc{anon2016Amyloi, title = {Amyloidopathy, Cholinopathy, Dopamine Responsiveness and Freezing of Gait in PD}, author = {Anonymous}, journal = {VA Office of Research and Development}, year = {2016}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings